Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Association of new obesity indices; visceral adiposity index and body adiposity index, with metabolic syndrome parameters in obese patients with or without type 2 diabetes mellitus

The Egyptian Journal of Internal Medicine volume 31, pages 620–628 (2019)Cite this article

Abstract

Background

Obesity is the cornerstone of metabolic syndrome (MetS); it is not possible to use BMI to differentiate between lean mass and fat mass. We aimed to investigate, for the first time, the possible association of new obesity indices; visceral adiposity index (VAI) and body adiposity index (BAI), with parameters of MetS in Egyptian obese patients.

Patients and methods

This was a case–control study that included unrelated 150 obese patients and 50 healthy controls. Obese patients were then subdivided into two subgroups, nondiabetic patients (n=85) and 65 patients with type 2 diabetes mellitus. We measured the anthropometric measures; BMI, waist/hip ratio, waist/height ratio, BAI, and VAI.

Results

Among obese patients, we found significant positive correlations between parameters of MetS and obesity indices. Among obesity indiced, the highly significant positive correlations were found between VAI and parameters of MetS. After adjusting for the traditional risk factors, logistic regression analysis test found that the VAI value was the best predictor of type 2 diabetes mellitus in comparison with BMI and BAI. Receiver operating characteristic curve was used to assess the power of obesity indices; the sensitivity and the specificity of BMI were 94.7 and 99.9%, for VAI, they were 74.4 and 99.9%, and, for BAI, they were 83.3 and 58%, respectively.

Conclusion

BMI is still the most powerful diagnostic tool for obesity. Although, in certain conditions, where there are limitations of using BMI, we can use other obesity indices, VAI and BAI could be used to discriminate cardiovascular risk among obese patients.

References

  1. Kirkendoll K, Clark PC, Grossniklaus D, Igho-Pemu P, Mullis R, Dunbar SB. Metabolic syndrome in African Americans: views on making lifestyle changes. J Transcult Nurs 2010; 21:104–113.

    Article  Google Scholar 

  2. Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 2012; 10:138–148.

    Article  CAS  Google Scholar 

  3. Walther G, Obert P, Dutheil F, Chapier R, Lesourd B, Naughton G, et al. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. Arterioscler Thromb Vasc Biol 2015; 35:1022–1029.

    Article  CAS  Google Scholar 

  4. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 2001; 25:1782–1788.

    Article  CAS  Google Scholar 

  5. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56:1113–1132.

    Article  Google Scholar 

  6. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011; 9: 48–61.

    Article  Google Scholar 

  7. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9 • 1 million participants. Lancet 2011; 377:557–567.

    Article  Google Scholar 

  8. Badran M, Laher I. Obesity in Arabic-speaking countries. J Obesity 2011. 24:1–9.

    Article  Google Scholar 

  9. Frühbeck G. Obesity: screening for the evident in obesity. Nat Rev Endocrinol 2012; 8:570–572.

    Article  Google Scholar 

  10. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766–781.

    Article  Google Scholar 

  11. Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, et al. The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study. Int J Obes Relat Metab Disord 2002; 26:789–796.

    Article  CAS  Google Scholar 

  12. Cornier MA, Després JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011; 124:1996–2019.

    Article  Google Scholar 

  13. InterAct C, Langenberg C, Sharp SJ, Schulze MB, Rolandsson O, Overved K, et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case cohort study. PLoS Med 2012; 9:e1001230.

    Article  Google Scholar 

  14. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010; 23:247–269.

    Article  Google Scholar 

  15. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010; 33:920–922.

    Article  Google Scholar 

  16. Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, et al. A better index of body adiposity. Obesity (Silver Spring) 2011; 19:1083–1089.

    Article  Google Scholar 

  17. Alberti KGM, Zimmet P, Shaw J, Group I. The metabolic syndrome – a new worldwide definition. Lancet 2005; 366:1059–1062.

    Article  Google Scholar 

  18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499–502.

    Article  CAS  Google Scholar 

  19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412–419.

    Article  CAS  Google Scholar 

  20. Pradeep AR, Nagpal K, Karvekar S, Patnaik K. Levels of lipocalin-2 in crevicular fluid and tear fluid in chronic periodontitis and obesity subjects. J Investig Clin Dent 2015; 19:1–7.

    Google Scholar 

  21. Gharipour M, Sarrafzadegan N, Sadeghi M, Andalib E, Talaie M, Shafie D. Predictors of metabolic syndrome in the Iranian population: waist circumference, body mass index, or waist to hip ratio? Cholesterol 2013; 24:2013.

    Google Scholar 

  22. Beydoun MA, Kuczmarski MT, Wang Y, Mason MA, Evans MK, Zonderman AB. Receiver-operating characteristics of adiposity for metabolic syndrome: the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study. Public Health Nutr 2011; 14:77–92.

    Article  Google Scholar 

  23. Tulloch-Reid MK, Williams DE, Looker HC, Hanson RL, Knowler WC. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care 2003; 26:2556–2561.

    PubMed  Google Scholar 

  24. Warne DK, Charles MA, Hanson RL, Jacobsson LT, McCance DR, Knowler WC. Comparison of body size measurements as predictors of NIDDM in Pima Indians. Diabetes Care 1995; 18:435–439.

    Article  CAS  Google Scholar 

  25. Hsieh SD, Yoshinaga H, Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 2003; 27:610–616

    Article  CAS  Google Scholar 

  26. MacKay MF, Haffner SM, Wagenknecht LE, D’Agostino RB Jr, Hanley AJ. Prediction of type 2 diabetes using alternate anthropometric measures in a multi-ethnic cohort: the insulin resistance atherosclerosis study. Diabetes Care 2009; 32:956–958.

    Article  Google Scholar 

  27. He YH, Chen YC, Jiang GX, Huang HE, Li R, Li XY. Evaluation of anthropometric indices for metabolic syndrome in Chinese adults aged 40 years and over. Eur J Nutr 2012; 51:81–87.

    Article  Google Scholar 

  28. Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) 2006; 30:475–483.

    Article  CAS  Google Scholar 

  29. Sayeed M, Mahtab H, Latif Z, Khanam P, Ahsan K, Banu A, et al. Waist-to-height ratio is a better obesity index than body mass index and waist-to-hip ratio for predicting diabetes, hypertension and lipidemia. Bangladesh Med Res Counc Bull 2003; 29:1.

    CAS  PubMed  Google Scholar 

  30. Kahn HS. Choosing an index for abdominal obesity: an opportunity for epidemiologic clarification. J Clin Epidemiol 1993; 46:491–494.

    Article  CAS  Google Scholar 

  31. Bennasar-Veny M, Lopez-Gonzalez AA, Tauler P, Cespedes ML, Vicente-Herrero T, Yañez A, et al. Body adiposity index and cardiovascular health risk factors in Caucasians: a comparison with the body mass index and others. PLoS One 2013; 8:e63999.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, 44519, Egypt

    Nearmeen M. Rashad & George Emad

Authors
  1. Nearmeen M. Rashad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Emad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nearmeen M. Rashad.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashad, N.M., Emad, G. Association of new obesity indices; visceral adiposity index and body adiposity index, with metabolic syndrome parameters in obese patients with or without type 2 diabetes mellitus. Egypt J Intern Med 31, 620–628 (2019). https://doi.org/10.4103/ejim.ejim_4_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_4_19

Keywords